IL140110A0 - Improvement of homogeneity and secretion of recombinant proteins in mammalian systems - Google Patents

Improvement of homogeneity and secretion of recombinant proteins in mammalian systems

Info

Publication number
IL140110A0
IL140110A0 IL14011000A IL14011000A IL140110A0 IL 140110 A0 IL140110 A0 IL 140110A0 IL 14011000 A IL14011000 A IL 14011000A IL 14011000 A IL14011000 A IL 14011000A IL 140110 A0 IL140110 A0 IL 140110A0
Authority
IL
Israel
Prior art keywords
interest
secretion
homogeneity
relates
improvement
Prior art date
Application number
IL14011000A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Priority to IL14011000A priority Critical patent/IL140110A0/xx
Priority to JP2002548147A priority patent/JP2004516830A/ja
Priority to AU2002222454A priority patent/AU2002222454B2/en
Priority to SI200130972T priority patent/SI1339855T1/sl
Priority to ES01999652T priority patent/ES2346956T3/es
Priority to AT01999652T priority patent/ATE471986T1/de
Priority to PT01999652T priority patent/PT1339855E/pt
Priority to IL15606801A priority patent/IL156068A0/xx
Priority to AU2245402A priority patent/AU2245402A/xx
Priority to US10/432,196 priority patent/US20040115775A1/en
Priority to EP01999652A priority patent/EP1339855B1/de
Priority to PCT/IL2001/001125 priority patent/WO2002046430A2/en
Priority to CA002429094A priority patent/CA2429094A1/en
Priority to DK01999652.9T priority patent/DK1339855T3/da
Priority to DE60142446T priority patent/DE60142446D1/de
Publication of IL140110A0 publication Critical patent/IL140110A0/xx
Priority to US10/858,928 priority patent/US7282352B2/en
Priority to CY20101100677T priority patent/CY1110670T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14011000A 2000-12-05 2000-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems IL140110A0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IL14011000A IL140110A0 (en) 2000-12-05 2000-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
IL15606801A IL156068A0 (en) 2000-12-05 2001-12-05 Method for improving homogeneity and/or secretion of a recombinant protein
EP01999652A EP1339855B1 (de) 2000-12-05 2001-12-05 Verbesserung der homogenität und sekretion von rekombinanten proteinen in säugetiersystemen
SI200130972T SI1339855T1 (sl) 2000-12-05 2001-12-05 Izboljĺ anje homogenosti in izloäśanja rekombinantnih proteinov v sesalskih sistemih
ES01999652T ES2346956T3 (es) 2000-12-05 2001-12-05 Mejora de la homogeneidad y secrecion de proteinas recombinantes en sistemas de mamiferos.
AT01999652T ATE471986T1 (de) 2000-12-05 2001-12-05 Verbesserung der homogenität und sekretion von rekombinanten proteinen in säugetiersystemen
PT01999652T PT1339855E (pt) 2000-12-05 2001-12-05 Melhoria da homogeneidade e da secreã†o de protenas recombinantes em sistemas de mamferos
JP2002548147A JP2004516830A (ja) 2000-12-05 2001-12-05 哺乳動物系における組換えタンパク質の均質性および分泌の改良
AU2245402A AU2245402A (en) 2000-12-05 2001-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
US10/432,196 US20040115775A1 (en) 2000-12-05 2001-12-05 Homogeneity and secretion of recombinant proteins in mammalian systems
AU2002222454A AU2002222454B2 (en) 2000-12-05 2001-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
PCT/IL2001/001125 WO2002046430A2 (en) 2000-12-05 2001-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
CA002429094A CA2429094A1 (en) 2000-12-05 2001-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
DK01999652.9T DK1339855T3 (da) 2000-12-05 2001-12-05 Forbedring af homogenitet og sekretion af rekombinante proteiner i pattedyrsystemer
DE60142446T DE60142446D1 (de) 2000-12-05 2001-12-05 Verbesserung der homogenität und sekretion von rekombinanten proteinen in säugetiersystemen
US10/858,928 US7282352B2 (en) 2000-12-05 2004-06-02 Homogeneity and secretion of recombinant proteins in mammalian systems
CY20101100677T CY1110670T1 (el) 2000-12-05 2010-07-20 Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL14011000A IL140110A0 (en) 2000-12-05 2000-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems

Publications (1)

Publication Number Publication Date
IL140110A0 true IL140110A0 (en) 2002-02-10

Family

ID=11074884

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14011000A IL140110A0 (en) 2000-12-05 2000-12-05 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems

Country Status (14)

Country Link
US (2) US20040115775A1 (de)
EP (1) EP1339855B1 (de)
JP (1) JP2004516830A (de)
AT (1) ATE471986T1 (de)
AU (2) AU2002222454B2 (de)
CA (1) CA2429094A1 (de)
CY (1) CY1110670T1 (de)
DE (1) DE60142446D1 (de)
DK (1) DK1339855T3 (de)
ES (1) ES2346956T3 (de)
IL (1) IL140110A0 (de)
PT (1) PT1339855E (de)
SI (1) SI1339855T1 (de)
WO (1) WO2002046430A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2864810A1 (en) * 2003-04-18 2004-11-04 Biogen Idec Ma, Inc. Polymer-conjugated glycosylated neublastin
GB0314856D0 (en) 2003-06-25 2003-07-30 Unitargeting Res As Protein expression system
WO2005030963A1 (en) 2003-09-26 2005-04-07 Applied Research Systems Ars Holding N.V. Leader sequences for use in production of proteins
US7598059B2 (en) 2003-10-02 2009-10-06 Biogen Idec Ma Inc. Neublastin expression constructs
NZ553420A (en) 2004-08-19 2010-02-26 Biogen Idec Inc Refolding transforming growth factor beta family proteins
EP2267024B1 (de) * 2005-06-03 2012-05-09 Ares Trading S.A. Herstellung von rekombinantem Il-18 bindendem Protein
JP2009501522A (ja) * 2005-07-12 2009-01-22 コドン デバイシズ インコーポレイテッド 生体触媒工学のための組成物及び方法
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
WO2008108344A1 (ja) * 2007-03-02 2008-09-12 Cellgentech, Inc. Ｌｃａｔ欠損症の遺伝子治療用細胞並びにこれを産生するのに用いられる複製欠損性レトロウイルスベクター及びプラスミド
JP5583005B2 (ja) 2007-05-01 2014-09-03 バイオジェン・アイデック・エムエイ・インコーポレイテッド 血管新生を増大させるための組成物および方法
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
US9157097B2 (en) 2008-09-25 2015-10-13 Proteovec Holding, L.L.C. Vectors for production of growth hormone
WO2010036976A2 (en) 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of antibodies
EP2417263B1 (de) 2009-04-09 2015-09-23 ProteoVec Holding L.L.C. Herstellung von proteinen unter verwendung von vektoren auf transposonbasis
CA2904146C (en) * 2013-03-08 2023-03-21 Neuclone Biologics Pty Ltd A cell expression system
DK2970456T3 (da) * 2013-03-14 2021-07-05 Translate Bio Inc Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer
JP6836999B2 (ja) 2015-03-24 2021-03-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ アデノ随伴ウイルス変異体及びその使用方法
SG11202009761YA (en) 2018-04-02 2020-10-29 Pact Pharma Inc Peptide-mhc compacts
CN111304243A (zh) * 2018-12-12 2020-06-19 普莱柯生物工程股份有限公司 一种高效表达外源蛋白的cho细胞株的构建方法、构建的cho细胞株及其应用
EP3999647A1 (de) * 2019-07-18 2022-05-25 Lysogene Zusammensetzungen und verfahren zur behandlung von sanfilippo-syndrom und anderen erkrankungen
WO2022042673A1 (zh) * 2020-08-28 2022-03-03 江苏恒瑞医药股份有限公司 用于降低异源多肽末端异质性的信号肽

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
US5417970A (en) * 1988-10-21 1995-05-23 Sanofi Drugs containing a glycosylated interleukin-2
JP4001925B2 (ja) * 1996-09-13 2007-10-31 トランスカーヨティック セラピーズ インク． α―ガラクトシダーゼＡ欠損症の治療
IL126562A0 (en) * 1998-10-14 1999-08-17 Interpharm Lab Ltd Expression and secretion of icil-1 receptor antagonist type ii

Also Published As

Publication number Publication date
EP1339855A2 (de) 2003-09-03
SI1339855T1 (sl) 2010-08-31
CY1110670T1 (el) 2015-06-10
AU2245402A (en) 2002-06-18
PT1339855E (pt) 2010-07-07
WO2002046430A2 (en) 2002-06-13
ATE471986T1 (de) 2010-07-15
DK1339855T3 (da) 2010-08-30
AU2002222454B2 (en) 2007-04-05
CA2429094A1 (en) 2002-06-13
DE60142446D1 (de) 2010-08-05
ES2346956T3 (es) 2010-10-22
US20040115775A1 (en) 2004-06-17
EP1339855B1 (de) 2010-06-23
WO2002046430A3 (en) 2003-01-03
JP2004516830A (ja) 2004-06-10
US20060234352A1 (en) 2006-10-19
US7282352B2 (en) 2007-10-16

Similar Documents

Publication Publication Date Title
CY1110670T1 (el) Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων
Barry et al. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells
WO2005017149A8 (en) Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
NZ232742A (en) Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced
CA2289912A1 (en) Human receptor proteins; related reagents and methods
ATE49233T1 (de) Vektoren zur transformation von hefe.
GR3026230T3 (en) Expression of recombinant polypeptides with improved purification
DK600486D0 (da) Igg-bindingsprotein
ATE121454T1 (de) Ubiquitinspezifische protease.
DK80886A (da) Biologisk aktive proteiner samt fremgangsmaade til deres fremstillingog anvendelse
Cool et al. Identification of a sorting signal for the regulated secretory pathway at the N-terminus of pro-opiomelanocortin
Lustbader et al. Expression of human chorionic gonadotropin uniformly labeled with NMR isotpes in Chinese hamster ovary cells: an advance toward rapid determination of glycoprotein structures
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
IL150676A0 (en) NOVEL STRa6 POLYPEPTIDES
EP3434686A1 (de) Verfahren zur herstellung und reinigung von hybriden oder nicht-hybriden rekombinanten glykoproteinhormonen, hybride oder nicht-hybride rekombinante glykoproteinhormone, expressionsvektoren und verwendungen der rekombinanten glykoproteinhormone
Zarreh-Hoshyari-Khah et al. Bioactivity of recombinant prorelaxin from the marmoset monkey
Canova-Davis et al. Transpeptidation during the analytical proteolysis of proteins
AU7873798A (en) N-terminally extended proteins expressed in yeast
AU5776799A (en) Modified hcv peptide vaccines
MXPA98007322A (es) Proteinas tirosina fosfatasas de las celulas hematopoyeticas.
EP0750040A3 (de) Varianten des Makrophagen-stimulierendes-Proteins und Verfahren zur ihrer Herstellung
WO2003025182A1 (fr) Adn de surexpression d'une hormone de croissance et utilisation
EP1427825B8 (de) Menschliche alpha2-delta4-calciumkanal-untereinheit codierende cdna
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods
PT1241179E (pt) Proteína humana possuindo actividade antiproliferativa in vitro